Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.58)
# 788
Out of 4,884 analysts
140
Total ratings
52.94%
Success rate
3.76%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $600 → $400 | $308.55 | +29.64% | 16 | May 14, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $239.68 | +29.34% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $319.75 | +17.28% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $8.29 | +44.75% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $33.31 | +155.18% | 17 | Dec 13, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $26.30 | +40.68% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $376.58 | +6.22% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $150.18 | +11.87% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $111.86 | +29.63% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $13.14 | +204.41% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.41 | +46.63% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $7.65 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $473.18 | +37.37% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $96.10 | +50.88% | 10 | Oct 28, 2022 |
UnitedHealth Group
May 14, 2025
Maintains: Outperform
Price Target: $600 → $400
Current: $308.55
Upside: +29.64%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $239.68
Upside: +29.34%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $319.75
Upside: +17.28%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $8.29
Upside: +44.75%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $33.31
Upside: +155.18%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $26.30
Upside: +40.68%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $376.58
Upside: +6.22%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $150.18
Upside: +11.87%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $111.86
Upside: +29.63%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $13.14
Upside: +204.41%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.41
Upside: +46.63%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $7.65
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $473.18
Upside: +37.37%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $96.10
Upside: +50.88%